Статья

Monoclonal antibody 2C5 specifically targets neutrophil extracellular traps

L. Mendes, K. Rostamizadeh, K. Gollomp, J. Myerson, O. Marcos-Contreras, M. Zamora, E. Luther, J. Brenner, N. Filipczak, X. Li, V. Torchilin,
2021

Neutrophils can release DNA and granular cytoplasmic proteins that form smooth filaments of stacked nucleosomes (NS). These structures, called neutrophil extracellular traps (NETs), are involved in multiple pathological processes, and NET formation and removal are clinically significant. The monoclonal antibody 2C5 has strong specificity toward intact NS but not to individual NS components, indicating that 2C5 could potentially target NS in NETs. In this study, NETs were generated in vitro using neutrophils and HL-60 cells differentiated into granulocyte-like cells. The specificity of 2C5 toward NETs was evaluated by ELISA, which showed that it binds to NETs with the specificity similar to that for purified nucleohistone substrate. Immunofluorescence showed that 2C5 stains NETs in both static and perfused microfluidic cell cultures, even after NET compaction. Modification of liposomes with 2C5 dramatically enhanced liposome association with NETs. Our results suggest that 2C5 could be used to identify and visualize NETs and serve as a ligand for NET-targeted diagnostics and therapies. © 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • L. Mendes
    Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, United States
  • K. Rostamizadeh
    Zanjan Pharmaceutical Nanotechnology Research Center, School of Pharmacy, Pharmaceutical Biomaterials Department, Zanjan University of Medical Sciences, Zanjan, Iran
  • K. Gollomp
    Division of Hematology, Children’s Hospital of Philadelphia, Philadelphia, PA, United States
  • J. Myerson
    Department of Systems Pharmacology and Translational Therapeutics, University of Philadelphia, Philadelphia, PA, United States
  • O. Marcos-Contreras
    Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, United States
  • M. Zamora
    Pulmonary, Allergy, Critical Care Division, University of PhiladelphiaPA, United States
  • E. Luther
    State Key Laboratory of Innovative Drug and Efficient Energy-Saving Pharmaceutical Equipment, Jiangxi University of Traditional Chinese Medicine, Nanchang, China
  • J. Brenner
    Department of Oncology, Radiotherapy and Plastic Surgery, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
  • N. Filipczak
  • X. Li
  • V. Torchilin
Название журнала
  • mAbs
Том
  • 12
Выпуск
  • 1
Страницы
  • -
Издатель
  • Bellwether Publishing, Ltd.
Тип документа
  • journal article
Источник
  • scopus